Form 4: Abbott Laboratories Director Patricia Paola Gonzalez Reports Acquisition of Stock Equivalent Units

Director Patricia Paola Gonzalez reports acquisition of 291 stock equivalent units in Abbott Laboratories on December 31, 2024, through director fees credited to a grantor trust.

Summary

• On December 31, 2024, Patricia Paola Gonzalez, a director of Abbott Laboratories, acquired 291 stock equivalent units.
• These units were obtained through director fees credited to a stock equivalent unit account under a grantor trust.
• The stock equivalent units earn the same return as if the fees were invested in Abbott shares and are generally paid out in cash at age 65 or upon retirement from the board.
• The price of the stock equivalent units was $113.11.
• Following the transaction, Gonzalez directly owns 4,125 stock equivalent units, which includes units acquired through dividend reinvestment.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. It reflects a routine transaction related to director compensation, indicating continued alignment of interests between the director and the company's shareholders.

Positives

• The acquisition of stock equivalent units demonstrates the director's continued investment in Abbott Laboratories.
• The dividend reinvestment feature further increases the director's stake in the company.

Future Outlook

The stock equivalent units will continue to earn returns equivalent to Abbott shares and will be paid out in cash generally at age 65 or upon retirement from the board.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in the company's securities. It reflects a director's ongoing compensation and investment in the company.

Related Party Transactions

• The acquisition of stock equivalent units through director fees can be considered a related party transaction.

Stakeholder Impact

• The transaction has a minimal direct impact on stakeholders, primarily providing transparency to shareholders regarding director compensation and ownership.

Key Dates